Thorsten Siegmund

CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus¹

H. Donner, Harald Rau, Paul G. Walfish et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 396 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Evaluation of Single Nucleotide Polymorphism Typing with Invader on PCR Amplicons and Its Automation

Charles A. Mein, Bryan J. Barratt, Michael Dunn et al. · Genome Research · 2000 · 215 citations · Full text

Veterinary Medicine, Genetics, Molecular Genetics +16

The NOD Idd9 Genetic Interval Influences the Pathogenicity of Insulitis and Contains Molecular Variants of Cd30, Tnfr2, and Cd137

Paul Lyons, Wayne W. Hancock, Paul Denny et al. · Immunity · 2000 · 165 citations · Full text

Life Sciences, Immunology, Internal Medicine +8

CTLA‐4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis

J. Braun, H. Donner, Thorsten Siegmund et al. · Tissue Antigens · 1998 · 139 citations

Life Sciences, Genetics, Molecular Genetics +16

Discrepancies Between Blood Glucose and Interstitial Glucose—Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target

Thorsten Siegmund, Lutz Heinemann, Ralf Kolassa et al. · Journal of Diabetes Science and Technology · 2017 · 105 citations · Full text

Medicine, Endocrinology, Diabetology +16